RecruitingNCT06982469

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Magnetic Resonance Imaging (MRI)/ Positron Emission Tomography (PET) Prostate-specific Membrane Antigen (PSMA) -Based Phase I-II Study of Salvage HDR Brachytherapy and External Beam Irradiation In Isolated Tumor Bed Relapses After Radical Prostatectomy


Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Enrollment

20 participants

Start Date

May 5, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about the long-term effects of HDR Brachytherapy in men with isolated local relapses after radical prostatectomy. The main question it aims to answer is: Does HDR Brachytherapy increase control rates and decreases complications compared with conventional External Irradiation? Participants will be asked to receive HDR brachytherapy as part of their regular medical care for isolated local relapses after radical prostatectomy


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a type of targeted radiation treatment called high dose rate (HDR) brachytherapy for men with prostate cancer that has come back in the prostate bed (where the prostate used to be) after having their prostate surgically removed. Brachytherapy involves placing tiny radioactive seeds or a probe very precisely inside the body to deliver a high dose of radiation directly to the tumor. **You may be eligible if...** - You have had your prostate surgically removed and your PSA (a blood marker for prostate cancer) is rising again - A PET scan (PSMA or choline) and MRI show that the cancer is isolated to the prostate bed — no spread elsewhere - The recurrent tumor can be seen on ultrasound for accurate placement of the radiation probe **You may NOT be eligible if...** - Your cancer has spread to distant locations (other organs or bones) - Cancer has only recurred in lymph nodes (not the prostate bed) - The prostate bed area has already been irradiated previously - Cancer is in multiple separate spots (not isolated) - You have a life expectancy of less than 5 years or cannot tolerate the procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONBrachytherapy

HDR brachytherapy


Locations(1)

Clínica Universidad de Navarra

Pamplona, Foral Community of Navarre, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06982469


Related Trials